Who Supplies Magnesium to India from BELGIUM

Importing finished pharmaceutical formulations containing magnesium into India requires compliance with the Drugs and Cosmetics Act, 1940, and associated rules. The Central Drugs Standard Control Organization (CDSCO) mandates that all imported drugs, including magnesium formulations, be registered and approved before distribution. The registration process involves obtaining an Import Registration Certificate and an Import License from CDSCO. The application must include detailed product information, manufacturing details, and evidence of compliance with Indian standards. The timeline for registration can vary but typically ranges from 6 to 12 months, depending on the complexity of the product and the completeness of the application. For formulations under HS Code 30049099, specific requirements include stability data demonstrating a shelf life of at least 24 months, batch manufacturing records, and a Certificate of Pharmaceutical Product (CoPP) from the manufacturer. Additionally, a No Objection Certificate (NOC) from the manufacturer is required to confirm that the product is authorized for export to India.

Imported magnesium formulations must undergo quality testing at CDSCO-approved laboratories to ensure they meet Indian Pharmacopoeia standards. Each batch requires a Certificate of Analysis (CoA) confirming compliance with specified quality parameters. Stability studies must be conducted under ICH Zone IV conditions, demonstrating the product's stability in India's climatic conditions. Upon arrival, customs drug inspectors perform port inspections, which may include sampling for laboratory analysis. If a batch fails quality testing, it may be rejected, re-exported, or destroyed, depending on the severity of the non-compliance.

In April 2025, the CDSCO introduced new regulations requiring import registration and licenses for all imported medicines, including finished formulations containing magnesium. This policy aims to prevent the sale of unapproved or illegal medicines in the Indian market. The regulations stipulate that drugs manufactured in Special Economic Zones (SEZs) for export purposes are not permitted for transfer to the Domestic Tariff Area (DTA) for sale and distribution. Additionally, the Production-Linked Incentive (PLI) scheme, introduced in 2020, has impacted the import of finished formulations by encouraging domestic manufacturing and reducing reliance on imports. These policy changes are part of India's broader strategy to enhance self-reliance in the pharmaceutical sector.

India imports finished magnesium formulations to meet the demand for specific dosage forms and patented or branded products not manufactured domestically. The domestic pharmaceutical industry may lack the capacity to produce certain specialized magnesium formulations, leading to import dependency. The market size for magnesium formulations in India is substantial, with a growing demand driven by increasing health awareness and the prevalence of magnesium deficiency-related conditions.

The import duty structure for finished pharmaceutical formulations under HS Code 30049099 includes a Basic Customs Duty (BCD) of 10%, an Integrated Goods and Services Tax (IGST) of 12%, and a Social Welfare Surcharge (SWS) of 10%. This results in a total landed duty of approximately 17.10%. There are no additional duties such as Anti-Dumping Duty or National Calamity Contingent Duty (NCCD) applicable to these imports. Exemptions or concessional rates are not available for imports from Belgium.

Belgium's pharmaceutical industry is renowned for its high-quality standards and innovative formulations. India sources magnesium formulations from Belgium due to the availability of patented products, specialized dosage forms, and advanced manufacturing technologies not present in the domestic market. While other countries like China, Germany, and the United States also supply magnesium formulations, Belgium's competitive advantage lies in its stringent quality control measures and adherence to international standards. Belgium's share in India's magnesium formulation imports is modest but significant, reflecting its niche position in the market.

India imports magnesium formulations from Belgium due to the availability of specialized products, patented formulations, and advanced manufacturing technologies not present in the domestic market. Belgium's adherence to international quality standards and its reputation for producing high-quality pharmaceutical products make it a preferred source for magnesium formulations.

Compared to other sources like China, Germany, and the United States, Belgium offers a competitive advantage in terms of product quality, regulatory compliance, and reliability. While other countries may offer lower prices, Belgium's products are often perceived as superior in quality, which justifies the higher cost for Indian importers seeking premium products.

Indian importers face several risks when sourcing magnesium formulations from Belgium, including currency fluctuations, regulatory changes, and potential shipping disruptions. While Belgium's political and economic stability reduces the risk of supply chain disruptions, importers should remain vigilant regarding changes in import policies and global trade dynamics.

1. 1Dual-Sourcing: Engage with multiple suppliers to mitigate the risk of supply chain disruptions.
2. 2Inventory Planning: Maintain adequate inventory levels to buffer against potential delays.
3. 3Payment Terms: Negotiate favorable payment terms, such as Letters of Credit (LC), to manage financial risk.
4. 4Supplier Qualification: Conduct thorough due diligence to ensure suppliers meet quality and regulatory standards.
5. 5Regulatory Compliance: Stay updated on India's import regulations and ensure all necessary documentation is in place.

1. 1DGFT Importer Exporter Code (IEC): Obtain an IEC from the Directorate General of Foreign Trade.
2. 2CDSCO Registration: Apply for registration under Form 40/41 for the specific magnesium formulation.
3. 3Import License: Secure an Import License from CDSCO.
4. 4No Objection Certificate (NOC): Obtain an NOC from the manufacturer confirming authorization for export to India.
5. 5Customs Broker: Engage a licensed customs broker for clearance procedures.
6. 6Advance Ruling: Seek an advance ruling from the Authority for Advance Rulings on classification and duty rates.